McCrindle BW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.

PubMed  Google Scholar 

McCrindle BW, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007;116(2):174–9.

PubMed  Google Scholar 

Amirsardari Z, et al. Exploring the association between serum Vitamin D levels and the development of coronary artery lesions in Kawasaki disease-a systematic review. Pediatr Rheumatol. 2024;22(1):71.

Google Scholar 

Singh S, Jindal AK, Pilania RK. Diagnosis of Kawasaki disease. Int J Rheum Dis. 2018;21(1):36–44.

PubMed  Google Scholar 

Forsey J. Mertens L, Atypical Kawasaki disease—a clinical challenge. Eur J Pediatr. 2012;171(4):609–11.

Zheng X, et al. N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease. Sci Rep. 2020;10(1):5130.

CAS  PubMed  PubMed Central  Google Scholar 

Sawaji Y, et al. Coronary risk factors in acute Kawasaki disease: correlation of serum immunoglobulin levels with coronary complications. Pediatr Int. 1998;40(3):218–25.

CAS  Google Scholar 

Kim J-J, et al. IgA levels are associated with coronary artery lesions in Kawasaki disease. Korean Circulation J. 2021;51(3):267–78.

CAS  PubMed  PubMed Central  Google Scholar 

Rivas MN, et al. Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation. Immunity. 2019;51(3):508-521. e6.

PubMed Central  Google Scholar 

Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18(1):1–15.

Google Scholar 

Shekarchian A, et al. Exploring the metabolomics profile of frailty-a systematic review. J Diabetes Metab Disord. 2024;23(1):289–303.

PubMed  PubMed Central  Google Scholar 

Vailati-Riboni M, et al. What are omics sciences?. In: Ametaj B, editor. Periparturient diseases of dairy cows. Cham: Springer; 2017. p. 1–7. https://doi.org/10.1007/978-3-319-43033-1_1

Böcker S, et al. Identifying metabolites with integer decomposition techniques, using only their mass spectrometric isotope patterns (Forschungsberichte der Technischen Fakultät, Abteilung Informationstechnik / Universität Bielefeld, Report 2007-01) Bielefeld: Universität Bielefeld. 2007.

Cao J-H. Local metabolism in preclinical disease models studied with mass spectrometry imaging. [Doctoral Thesis, Maastricht University]. Maastricht University. 2022. https://doi.org/10.26481/dis.20221006jc

Nordström A, Lewensohn R. Metabolomics: moving to the clinic. J Neuroimmune Pharmacol. 2010;5:4–17.

PubMed  Google Scholar 

Zhang A-H, Sun H, Wang X-J. Recent advances in metabolomics in neurological disease, and future perspectives. Anal Bioanal Chem. 2013;405:8143–50.

CAS  PubMed  Google Scholar 

Tounta V, et al. Metabolomics in infectious diseases and drug discovery. Molecular Omics. 2021;17(3):376–93.

CAS  PubMed  PubMed Central  Google Scholar 

Shekarchian A, et al. Exploring the metabolomics profile of frailty: a systematic review. J Diabetes Metab Disord. 2024;23(1):289–303.

PubMed  PubMed Central  Google Scholar 

Amirsardari Z, et al. Metabolomics profiling in venous thromboembolism and its chronic sequelae-a systematic review. Thromb Res. 2025;249:109309.

CAS  PubMed  Google Scholar 

Ahn JK, et al. Potential metabolomic biomarkers for reliable diagnosis of Behcet’s disease using gas chromatography/time-of-flight-mass spectrometry. Joint Bone Spine. 2018;85(3):337–43.

CAS  PubMed  Google Scholar 

Demir S, et al. Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis. Semin Arthritis Rheum. 2020;50(6):1238–44.

CAS  PubMed  Google Scholar 

Morris AD, et al. Biomarkers in ANCA-associated vasculitis: potential pitfalls and future prospects. Kidney360. 2021;2(3):586.

PubMed  PubMed Central  Google Scholar 

Petelytska L, et al. FRI0268 changes in serum levels of the biomarkers of vascular wall damage in the treatment of systemic necrotizing vasculitis (SNV). Ann Rheum Dis. 2015;74(Suppl 2):521.

Google Scholar 

Zhu Q, et al. Palmitic acid, a critical metabolite, aggravates cellular senescence through reactive oxygen species generation in Kawasaki disease. Front Pharmacol. 2022;13:809157.

CAS  PubMed  PubMed Central  Google Scholar 

Qian G, et al. Leukocyte proteomics coupled with serum metabolomics identifies novel biomarkers and abnormal amino acid metabolism in Kawasaki disease. J Proteomics. 2021;239:104183.

CAS  PubMed  Google Scholar 

Chen Z, et al. Distinctive serum lipidomic profile of IVIG-resistant Kawasaki disease children before and after treatment. PLoS ONE. 2023;18(3):e0283710.

CAS  PubMed  PubMed Central  Google Scholar 

Dambrova M, et al. Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials. Pharmacol Rev. 2022;74(3):506–51.

CAS  PubMed  Google Scholar 

Fan X, et al. Metabolic profiling reveals altered tryptophan metabolism in patients with kawasaki disease. Front Mol Biosci. 2023;10:1180537.

CAS  PubMed  PubMed Central  Google Scholar 

Li Y-C, et al. Aneurysmal subarachnoid hemorrhage onset alters pyruvate metabolism in poor-grade patients and clinical outcome depends on more: a cerebrospinal fluid metabolomic study. ACS Chem Neurosci. 2018;10(3):1660–7.

PubMed  Google Scholar 

Su J, et al. Diagnosis of unruptured intracranial aneurysm by high-performance serum metabolic fingerprints. Small Methods. 2023;7:2201486.

CAS  Google Scholar 

Iizuka T, et al. Nitric oxide and aneurysm formation in Kawasaki disease. Acta Paediatr. 1997;86(5):470–3.

CAS  PubMed  Google Scholar 

Yoshimura K, et al. Increased nitric oxide production by neutrophils in early stage of Kawasaki disease. Eur J Pediatr. 2009;168:1037–41.

CAS  PubMed  Google Scholar 

Tsukahara H, et al. Endogenous nitric oxide production in Kawasaki disease. Scand J Clin Lab Invest. 1997;57(1):43–7.

CAS  PubMed  Google Scholar 

Huang Y-H, et al. Asymmetric and symmetric dimethylarginine are associated with coronary artery lesions in Kawasaki disease. J Pediatr. 2014;165(2):295–9.

CAS  PubMed  Google Scholar 

Lu AY, et al. Cerebrospinal fluid untargeted metabolomic profiling of aneurysmal subarachnoid hemorrhage: an exploratory study. Br J Neurosurg. 2018;32(6):637–41.

PubMed  Google Scholar